Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;20(10):1422-49.
doi: 10.2174/13816128113199990463.

Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Affiliations
Review

Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Lucy Sanchez-Covarrubias et al. Curr Pharm Des. 2014.

Abstract

The blood-brain barrier (BBB) and blood-cerebrospinal fluid (BCSF) barriers are critical determinants of CNS homeostasis. Additionally, the BBB and BCSF barriers are formidable obstacles to effective CNS drug delivery. These brain barrier sites express putative influx and efflux transporters that precisely control permeation of circulating solutes including drugs. The study of transporters has enabled a shift away from "brute force" approaches to delivering drugs by physically circumventing brain barriers towards chemical approaches that can target specific compounds of the BBB and/or BCSF barrier. However, our understanding of transporters at the BBB and BCSF barriers has primarily focused on understanding efflux transporters that efficiently prevent drugs from attaining therapeutic concentrations in the CNS. Recently, through the characterization of multiple endogenously expressed uptake transporters, this paradigm has shifted to the study of brain transporter targets that can facilitate drug delivery (i.e., influx transporters). Additionally, signaling pathways and trafficking mechanisms have been identified for several endogenous BBB/BCSF transporters, thereby offering even more opportunities to understand how transporters can be exploited for optimization of CNS drug delivery. This review presents an overview of the BBB and BCSF barrier as well as the many families of transporters functionally expressed at these barrier sites. Furthermore, we present an overview of various strategies that have been designed and utilized to deliver therapeutic agents to the brain with a particular emphasis on those approaches that directly target endogenous BBB/BCSF barrier transporters.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cross section of brain capillary endothelial cell. Factors secreted by astrocytes and pericytes, as well as neuronal input help maintain tight junction integrity and function, allowing for limited paracellular permeability of substances into the CNS.
Figure 2
Figure 2
Methods of xenobiotic transport across the blood-barrier
Figure 3
Figure 3
Transport mechanisms expressed in cells comprising the neurovascular unit. A multitude of transporters are expressed on capillary endothelial cells, astrocytes, microglia, and neurons. Transporter systems aid in transport of nutrients, peptides, and ions into the brain parenchyma and as well as efflux of waste and potentially neurotoxic substance out of the brain. Arrows indicate the proposed direction of substrate transport.
Figure 4
Figure 4
Transporter systems expressed on at the BCSF barrier in choroid plexus epithelial cells.

References

    1. Ronaldson PTD. Pharmacological Reviews. 2012. TP. Targeted Drug Delivery to Treat Pain and Cerebral Hypoxia. Epub in press. - PMC - PubMed
    1. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiological reviews. 1997;77(3):731–58. Epub 1997/07/01. - PubMed
    1. Oldendorf WH, Cornford ME, Brown WJ. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Annals of neurology. 1977;1(5):409–17. Epub 1977/05/01. - PubMed
    1. Takakura Y, Audus KL, Borchardt RT. Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells. Advances in pharmacology (San Diego, Calif) 1991;22:137–65. Epub 1991/01/01. - PubMed
    1. Fenstermacher J, Gross P, Sposito N, Acuff V, Pettersen S, Gruber K. Structural and functional variations in capillary systems within the brain. Annals of the New York Academy of Sciences. 1988;529:21–30. - PubMed

MeSH terms

Substances